National Bank of Canada’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.9M | Sell |
458,653
-82,878
| -15% | -$6.48M | 0.03% | 318 |
|
|
2025
Q1 | $39.2M | Buy |
541,531
+209,144
| +63% | +$15.2M | 0.04% | 298 |
|
|
2024
Q4 | $24.6M | Buy |
332,387
+28,534
| +9% | +$2.11M | 0.03% | 387 |
|
|
2024
Q3 | $20.1M | Buy |
303,853
+65,982
| +28% | +$4.35M | 0.02% | 412 |
|
|
2024
Q2 | $21.5M | Buy |
237,871
+34,635
| +17% | +$3.12M | 0.03% | 320 |
|
|
2024
Q1 | $17.6M | Sell |
203,236
-11,625
| -5% | -$1.01M | 0.03% | 372 |
|
|
2023
Q4 | $16.2M | Buy |
214,861
+9,352
| +5% | +$707K | 0.03% | 387 |
|
|
2023
Q3 | $14.2M | Buy |
205,509
+33,350
| +19% | +$2.3M | 0.02% | 403 |
|
|
2023
Q2 | $15.8M | Buy |
172,159
+77,698
| +82% | +$7.12M | 0.03% | 364 |
|
|
2023
Q1 | $7.79M | Buy |
94,461
+53,633
| +131% | +$4.42M | 0.02% | 418 |
|
|
2022
Q4 | $3.05M | Sell |
40,828
-12,565
| -24% | -$937K | 0.01% | 699 |
|
|
2022
Q3 | $4.41M | Buy |
53,393
+34,177
| +178% | +$2.82M | 0.02% | 492 |
|
|
2022
Q2 | $1.83M | Sell |
19,216
-2,585
| -12% | -$246K | 0.01% | 674 |
|
|
2022
Q1 | $2.57M | Sell |
21,801
-8,439
| -28% | -$993K | 0.01% | 659 |
|
|
2021
Q4 | $3.9M | Buy |
+30,240
| New | +$3.9M | 0.01% | 531 |
|